Ambri revenue, loss down
Thursday, 25 August, 2005
Ambri (ASX:ABI) saw a decrease in its revenue for the 2004-05 financial year of 27 per cent to $1 million (from $1.4 million in the previous year) but the company's loss was also down 22 per cent to $9 million.
Total expenses for 2004-05 were $10 million compared with $12.8 million in 2003-04, due to a reduction in headcount and R&D spending. The company halved its workforce from 76 to 32 people over the financial year, reducing employee expenses to $4.6 million.
Ambri had cash assets of $10.9 million at June 30, 2005.
Unhealthy Western diet could accelerate cognitive decline
An unhealthy Western-style diet is associated with a faster cognitive decline in people with a...
Cancer drug enters clinical trials based on a false mechanism
A cancer drug currently being tested in patients appears to have entered clinical trials based on...
Russia insists there is "no plague case" following lab worker death
Russian health authorities say there is no evidence that pneumonic plague played a part in the...
